Skip to main content
. 2014 Aug 6;41(2):419–428. doi: 10.1093/schbul/sbu099

Fig. 1.

Fig. 1.

Shown analytes were the most frequently appearing in 20 5-by-5-by-5 cross-validation trials, each trial testing 125 partitions to generate ~80% subsets of UC, CHR-NP, and CHR-P samples.